Search Results

Site Search

1863: Mayo and the Military #ThrowbackThursday - Insights

In May 1863, while the Battle of Chancellorsville was raging in Virginia and shortly before the climactic Battle of Gettysburg in Pennsylvania, an English-born, Minnesota-based physician named William Worrall Mayo, M.D., signed an oath of...

February 2023 - Hematopathology Case Two - Insights

This "Pathways" program provides a Clinical Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Hematopathology.

January 2022 - Cardiovascular Pathology - Insights

This "Pathways" program provides an Anatomic Pathology case that includes a history, potential answers, rationale, and relevant references. This case sub-specialty is Cardiovascular Pathology.

Mucopolysaccharidosis - Insights

Learn more about how Mayo Clinic Laboratories’ testing for mucopolysaccharidosis can assist with diagnosis and disease management.

Therapeutic drug monitoring - Insights

Learn more about Mayo Clinic Laboratories’ clinically driven approach to therapeutic drug monitoring.

Testing Archives - Page 5 of 26 - Insights

Skip to Content MayoACCESS MayoLINK...

Leveraging Lessons from the Past - Insights

Sharing lessons learned from past process improvement and other projects conducted at Mayo Clinic.

Mayo Clinic Laboratories and Lucence announce strategic collaboration to enhance cancer testing services - Insights

Mayo Clinic Laboratories and Lucence are expanding access to advanced cancer testing worldwide with LiquidHALLMARK®, a next-generation liquid biopsy that provides actionable genomic insights. This collaboration empowers physicians to...

Familial Variant Targeted Testing (FMTT) - Insights

In this month's "Hot Topic," Megan Hoenig, M.S., M.P.H., CGC, a licensed and certified genetic counselor with the Division of Laboratory Genetics and Genomics at Mayo Clinic Laboratories, describes the principles and benefits of Familial...

Classical Hematology Conference - Insights

This hybrid conference will be held Oct. 15–17, 2024, in Scottsdale, Arizona, and will provide reviews and updates about the laboratory and clinical aspects of nonmalignant hematology and bleeding and thrombotic disorders.